Improvements in blood and fitness tracker biomarkers in a longitudinal real-world cohort of digital health platform users.

Nimisha Schneider¹, Paul Fabian¹, Michelle Cawley¹, Bartek Nogal¹, Gil Blander¹, Renee Deehan¹

¹InsideTracker, One Broadway, Cambridge, Massachusetts, United States of America.

Abstract

Digital health technologies offer new opportunities for personalized health management and disease prevention. In this retrospective, long-term longitudinal study of over 20,000 users of a digital health platform (DHP), we aimed to determine whether improvements in health-related biomarkers could be observed in users and, if so, how they were maintained over time. We further explored whether genet…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.